ZNF641 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.522230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.486800E-01
Normal-vs-Stage2
1.507690E-02
Normal-vs-Stage3
7.810300E-02
Normal-vs-Stage4
2.653200E-01
Stage1-vs-Stage2
2.564000E-01
Stage1-vs-Stage3
6.073500E-02
Stage1-vs-Stage4
9.000000E-01
Stage2-vs-Stage3
1.295020E-03
Stage2-vs-Stage4
2.697600E-01
Stage3-vs-Stage4
6.662500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.651640E-02
Normal-vs-AfricanAmerican
1.781210E-01
Normal-vs-Asian
1.038320E-02
Caucasian-vs-AfricanAmerican
6.187200E-01
Caucasian-vs-Asian
1.534980E-01
AfricanAmerican-vs-Asian
2.219800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.835600E-02
Normal-vs-Female
8.756800E-03
Male-vs-Female
4.949800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.309200E-01
Normal-vs-Age(41-60Yrs)
4.865900E-02
Normal-vs-Age(61-80Yrs)
1.155620E-02
Normal-vs-Age(81-100Yrs)
8.459600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.151200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.992800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.102380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.157900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.436200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.221000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.025000E-03
Normal-vs-Daily Drinker
7.838900E-04
Normal-vs-Weekly Drinker
2.855800E-02
Normal-vs-Occasional Drinker
8.483800E-03
Normal-vs-Social Drinker
5.516000E-02
Non Drinker-vs-Daily Drinker
3.453000E-01
Non Drinker-vs-Weekly Drinker
7.033400E-01
Non Drinker-vs-Occasional Drinker
4.797600E-01
Non Drinker-vs-Social Drinker
9.649600E-02
Daily Drinker-vs-Weekly Drinker
2.449000E-01
Daily Drinker-vs-Occasional Drinker
9.732300E-02
Daily Drinker-vs-Social Drinker
1.208200E-02
Weekly Drinker-vs-Occasional Drinker
8.302200E-01
Weekly Drinker-vs-Social Drinker
2.947400E-01
Occasional Drinker-vs-Social Drinker
2.983000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.031830E-01
Normal-vs-Grade 2
4.796200E-02
Normal-vs-Grade 3
3.302100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.816200E-01
Grade 1-vs-Grade 3
6.150600E-01
Grade 1-vs-Grade 4
1.031830E-01
Grade 2-vs-Grade 3
1.580620E-01
Grade 2-vs-Grade 4
4.796200E-02
Grade 3-vs-Grade 4
3.302100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.356400E-03
Normal-vs-NonDiabetic
6.821600E-03
Diabetic-vs-NonDiabetic
7.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.997600E-03
Normal-vs-NoPancreatitis
7.961600E-03
Pancreatitis-vs-NoPancreatitis
5.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.501900E-02
Normal-vs-N1
1.617530E-02
N0-vs-N1
7.428400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.609900E-02
Normal-vs-TP53-NonMutant
1.781590E-01
TP53-Mutant-vs-TP53-NonMutant
8.813700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
